The Jason Lewis Lab Group

The Lewis lab research interests are focused on the development of radiopharmaceuticals for targeted diagnosis and treatment of cancer. By combining small- and biomolecule-based targeting agents with positron-emitting or therapeutic radioisotopes, we can interrogate molecular profiles of cancer using noninvasive nuclear imaging or treat tumors specifically with endoradiotherapy. Our research program is a molecular-imaging-based program focused on the targeting of nonstandard nuclides, with an emphasis on developing these novel radiopharmaceuticals for clinical translation. A few examples of our work are given below.

Learn more
Pictured: Jason Lewis

Jason S. Lewis, PhD

Emily Tow Jackson Chair in Oncology

Professor

Research Focus

Radiochemist Jason Lewis develops molecular imaging agents for the imaging and therapy of cancer.

Education

PhD, The University of Kent (UK)

Lab Members

Selected Achievements
  • Distinguished Investigator Award, Academy Radiology Research (2014)
  • Fellow, World Molecular Imaging Society (FWMIS) (2015)
  • Michael J. Welch Award, SNMMI (2017)
  • Fellow, Society of Nuclear Medicine and Molecular Imaging (FSNMMI) (2019)
  • Paul C. Aebersold Award, ERF-SNMMI (2019)
Read more
  • NCI R35 Outstanding Investigator Award (2019-2026)